Entrepreneurs: 4 ways to slash debt for good
Politics & Economics

Entrepreneurs: 4 ways to slash debt for good

Being an entrepreneur takes extreme determination and bold decisions. These same traits can be critical weapons in winning the battle against debt. If you’re an entrepreneur who’s worried about debt — whether it’s $5,000 or upward of $100,000 — now is the time to act to cut back. These four tips from financial experts and entrepreneurs … Continue reading

The $50,000 impact of pre-K
Culture / Education / Politics & Economics

The $50,000 impact of pre-K

  As much as preschool is about giving young children a head start in learning, it’s also about economics. For New York City, one of the country’s largest and most racially segregated school districts, the start of free preschool for all 4-year-olds has major financial implications moving forward — and some working parents are already … Continue reading

$100 billion later, Afghanistan on the brink
Politics & Economics

$100 billion later, Afghanistan on the brink

Afghanistan’s economy is worsening and its security deteriorating despite more than a decade of U.S.-led reconstruction efforts and more than $100 billion poured into the country, according to the Special Inspector General for Afghanistan Reconstruction, an independent oversight agency created by Congress in 2008. The agency’s investigation, conducted between October and December of last year, … Continue reading

Democratic Debate Breaks Records in Live-Streaming and TV
Politics & Economics

Democratic Debate Breaks Records in Live-Streaming and TV

Tuesday’s presidential debate on CNN was the highest-rated and most viewed debate for the Democratic Party ever, preliminary numbers from Nielsen show. It also set the all-time record for news live-streaming. A whopping 15.3 million viewers tuned in to the presidential debate featuring Vermont Sen. Bernie Sanders, former Secretary of State Hillary Clinton, former Rhode Island Gov. … Continue reading

Investing in Biopharma? Four things to know about industry leader Gilead Sciences
Politics & Economics

Investing in Biopharma? Four things to know about industry leader Gilead Sciences

By Marguerite Ward 1. Gilead’s numbers are looking good: The California-based biopharmaceutical company continues to see success with its HIV drugs (Stribild, Viread ect.) and Hepatitis C drugs (Sovaldi and Harvoni). Gilead’s stock is up 6.24 percent year-to-date at $100.14, swiftly outpacing the NASDAQ composite index’s 1 percent decline over the same period. Its earnings per … Continue reading